WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.
Jason J LukeRiyue BaoRandy F SweisStefani SprangerThomas F GajewskiPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
Activation of tumor-intrinsic WNT/β-catenin signaling is enriched in non-T-cell-inflamed tumors. These data provide a strong rationale for development of pharmacologic inhibitors of this pathway with the aim of restoring immune cell infiltration and augmenting immunotherapy.See related commentary by Dangaj et al., p. 2943.